Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Williams

Showing results (91-100 of 212) with videos related to

Pageof 22
Sort By:
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|May 20, 2021
Validation of the liver traffic light test as a predictive model for survival and development of liver-related eventsRochelle Sylvester, Theresa J Hydes, Alan Hales, et al.
Biochemical Society Transactions|July 21, 2009
Form and flexibility in phosphoinositide 3-kinasesRoger Williams, Alex Berndt, Simon Miller, et al.
The AAPS Journal|April 6, 2006
Equivalence studies for complex active ingredients and dosage formsLokesh Bhattycharyya, Roger Dabbah, Walter Hauck, et al.
Antiviral Research|January 11, 2007
Direct evidence for immunomodulatory properties of ribavirin on T-cell reactivity to hepatitis C virusEirini I Rigopoulou, William G H Abbott, Roger Williams, et al.
Journal of Hepatology|December 14, 2002
Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitisRajiv Jalan, Sambit Sen, Christian Steiner, et al.
Transplantation|August 24, 2007
Protocols and mechanisms for remote ischemic preconditioning: a novel method for reducing ischemia reperfusion injurySanjeev Kanoria, Rajiv Jalan, Alexander M Seifalian, et al.
British Journal of Hospital Medicine (London, England : 2005)|January 10, 2018
Clinical NewsSarah Hosgood, Roger Williams, J Brugada, et al.
Immunobiology|July 4, 2012
Induction of CD152 (CTLA-4) and LAP (TGF-β1) in human Foxp3- CD4+ CD25- T cells modulates TLR-4 induced TNF-α productionSandra Boswell, Ansar A Pathan, Stephen P Pereira, et al.
Journal of Hepatology|April 29, 2015
Acute liver failure: A curable disease by 2024?William Bernal, William M Lee, Julia Wendon, et al.
Immunology|March 24, 2011
Induction of latency-associated peptide (transforming growth factor-β(1)) expression on CD4+ T cells reduces Toll-like receptor 4 ligand-induced tumour necrosis factor-α production in a transforming growth factor-β-dependent mannerSandra Boswell, Shayan Sharif, Akeel Alisa, et al.
Pageof 22

Showing results (91-100 of 212) with videos related to

Sort By:
Pageof 22
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|May 20, 2021
Validation of the liver traffic light test as a predictive model for survival and development of liver-related eventsRochelle Sylvester, Theresa J Hydes, Alan Hales, et al.
Biochemical Society Transactions|July 21, 2009
Form and flexibility in phosphoinositide 3-kinasesRoger Williams, Alex Berndt, Simon Miller, et al.
The AAPS Journal|April 6, 2006
Equivalence studies for complex active ingredients and dosage formsLokesh Bhattycharyya, Roger Dabbah, Walter Hauck, et al.
Antiviral Research|January 11, 2007
Direct evidence for immunomodulatory properties of ribavirin on T-cell reactivity to hepatitis C virusEirini I Rigopoulou, William G H Abbott, Roger Williams, et al.
Journal of Hepatology|December 14, 2002
Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitisRajiv Jalan, Sambit Sen, Christian Steiner, et al.
Transplantation|August 24, 2007
Protocols and mechanisms for remote ischemic preconditioning: a novel method for reducing ischemia reperfusion injurySanjeev Kanoria, Rajiv Jalan, Alexander M Seifalian, et al.
British Journal of Hospital Medicine (London, England : 2005)|January 10, 2018
Clinical NewsSarah Hosgood, Roger Williams, J Brugada, et al.
Immunobiology|July 4, 2012
Induction of CD152 (CTLA-4) and LAP (TGF-β1) in human Foxp3- CD4+ CD25- T cells modulates TLR-4 induced TNF-α productionSandra Boswell, Ansar A Pathan, Stephen P Pereira, et al.
Journal of Hepatology|April 29, 2015
Acute liver failure: A curable disease by 2024?William Bernal, William M Lee, Julia Wendon, et al.
Immunology|March 24, 2011
Induction of latency-associated peptide (transforming growth factor-β(1)) expression on CD4+ T cells reduces Toll-like receptor 4 ligand-induced tumour necrosis factor-α production in a transforming growth factor-β-dependent mannerSandra Boswell, Shayan Sharif, Akeel Alisa, et al.
Pageof 22